Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07569887 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Exploratory Study of Cerebral Perfusion and Metabolic Alterations and Neurocognitive Disorders in Patients With Unruptured Arteriovenous Malformations Before and After Surgical Treatment

Name: Exploratory Study of Cerebral Perfusion and Metabolic Alterations and Neurocognitive Disorders in Patients With Unruptured Arteriovenous Malformations Before and After Surgical Treatment — clinical trial record (NCT07569887)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: APEMMAV-NR

StatusRecruiting

PhaseNot applicable

SponsorUniversity Hospital, Montpellier

Started2026-06-16

View on ClinicalTrials.gov ↗

Amendment history

2026-07-02

Study Status, Contacts/Locations v1

Recruitment opened

Primary completion pushed: 2028-11 → 2028-12

Completion pushed: 2028-11 → 2028-12

Start dateestimated 2026-05→confirmed 2026-06-16

Study sitesdetails revised at 1 of 1 site

2026-05-04

Original filing

University Hospital, Montpellier

303 trials monitored

See 6 trials at risk

The goal of the clinical trial is to describe perfusion and metabolic alterations in different brain regions before and six months after surgical treatment of arteriovenous malformations in adult patients with unruptured arteriovenous malformations.

Trial Details

NCT Number	NCT07569887
Lead Sponsor	University Hospital, Montpellier
Conditions	Unruptured Brain Arteriovenous Malformation
Enrollment	10 participants
Start Date	2026-06-16
Primary Completion	2028-12 (estimated)
Study Completion	2028-12 (estimated)
Updated on ClinicalTrials.gov	2026-07-07